IMA
Price
$17.28
Change
-$0.62 (-3.46%)
Updated
Aug 1 closing price
Capitalization
192.77M
5 days until earnings call
MRSN
Price
$6.60
Change
-$0.25 (-3.65%)
Updated
Aug 1 closing price
Capitalization
32.9M
4 days until earnings call
Interact to see
Advertisement

IMA vs MRSN

Header iconIMA vs MRSN Comparison
Open Charts IMA vs MRSNBanner chart's image
ImageneBio
Price$17.28
Change-$0.62 (-3.46%)
Volume$11.73K
Capitalization192.77M
Mersana Therapeutics
Price$6.60
Change-$0.25 (-3.65%)
Volume$110.63K
Capitalization32.9M
IMA vs MRSN Comparison Chart in %
Loading...
IMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMA vs. MRSN commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMA is a Hold and MRSN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (IMA: $17.28 vs. MRSN: $6.60)
Brand notoriety: IMA and MRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMA: 4% vs. MRSN: 47%
Market capitalization -- IMA: $192.77M vs. MRSN: $32.9M
IMA [@Biotechnology] is valued at $192.77M. MRSN’s [@Biotechnology] market capitalization is $32.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMA’s FA Score shows that 1 FA rating(s) are green whileMRSN’s FA Score has 0 green FA rating(s).

  • IMA’s FA Score: 1 green, 4 red.
  • MRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, IMA is a better buy in the long-term than MRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMA’s TA Score shows that 5 TA indicator(s) are bullish while MRSN’s TA Score has 4 bullish TA indicator(s).

  • IMA’s TA Score: 5 bullish, 3 bearish.
  • MRSN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, IMA is a better buy in the short-term than MRSN.

Price Growth

IMA (@Biotechnology) experienced а +1108.39% price change this week, while MRSN (@Biotechnology) price change was +2038.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.14%. For the same industry, the average monthly price growth was +15.55%, and the average quarterly price growth was +36.18%.

Reported Earning Dates

IMA is expected to report earnings on Nov 06, 2025.

MRSN is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+0.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMA($193M) has a higher market cap than MRSN($32.9M). IMA YTD gains are higher at: 953.659 vs. MRSN (-81.538).
IMAMRSNIMA / MRSN
Capitalization193M32.9M587%
EBITDAN/A-68.42M-
Gain YTD953.659-81.538-1,170%
P/E RatioN/AN/A-
RevenueN/A34M-
Total CashN/AN/A-
Total DebtN/A24.6M-
FUNDAMENTALS RATINGS
MRSN: Fundamental Ratings
MRSN
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMAMRSN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COOP174.2618.54
+11.91%
Mr Cooper Group
ITRM0.73N/A
+0.11%
Iterum Therapeutics plc
ARAY1.28-0.03
-2.29%
Accuray
PYPL67.11-1.65
-2.40%
PayPal Holdings
TRUP46.21-1.20
-2.53%
Trupanion

IMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMA has been closely correlated with CELC. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMA jumps, then CELC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMA
1D Price
Change %
IMA100%
-3.46%
CELC - IMA
87%
Closely correlated
+1.90%
MRSN - IMA
65%
Loosely correlated
-3.65%
SLXN - IMA
59%
Loosely correlated
-37.88%
TRML - IMA
23%
Poorly correlated
-6.77%
MNOV - IMA
23%
Poorly correlated
+7.92%
More